Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · IEX Real-Time Price · USD

9.30

-0.26 (-2.72%)

At close: Jul 2, 2024, 4:00 PM

9.35

+0.05 (0.54%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Arcutis Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-262.14	-311.46	-206.36	-135.68	-42	Upgrade
Depreciation & Amortization	1.88	1.25	0.76	0.46	0.2	Upgrade
Share-Based Compensation	38.81	32.68	23.89	7.94	0.82	Upgrade
Other Operating Activities	-25.61	19.81	7.07	14.25	-1.86	Upgrade
Operating Cash Flow	-247.06	-257.72	-174.63	-113.03	-42.84	Upgrade
Capital Expenditures	-0.43	-0.33	-1	-0.32	-0.3	Upgrade
Change in Investments	180.66	-63.92	-74.96	-181.5	-26.03	Upgrade
Other Investing Activities	-	-22.95	-	-	-	Upgrade
Investing Cash Flow	180.23	-87.2	-75.95	-181.82	-26.33	Upgrade
Share Issuance / Repurchase	101.32	178.99	209.6	298.15	0.27	Upgrade
Debt Issued / Paid	0	122.81	72.35	0	-1.4	Upgrade
Other Financing Activities	-	-	-	-	94.24	Upgrade
Financing Cash Flow	101.32	301.8	281.95	298.15	93.1	Upgrade
Exchange Rate Effect	-0.05	0	0	0	0	Upgrade
Net Cash Flow	34.45	-43.12	31.37	3.29	23.94	Upgrade
Free Cash Flow	-247.49	-258.05	-175.62	-113.35	-43.13	Upgrade
Free Cash Flow Margin	-415.20%	-7000.76%	-	-	-	Upgrade
Free Cash Flow Per Share	-3.57	-4.69	-3.56	-3.18	-23.40	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).